莫桑比克尚未符合抗逆转录病毒疗法 (ART) 资格的艾滋病毒患者中,与未能入诊相关的因素。
Factors associated with loss to clinic among HIV patients not yet known to be eligible for antiretroviral therapy (ART) in Mozambique.
机构信息
Spencer Cox Center for Health, St. Luke's Hospital, New York, NY 10025, United States.
出版信息
J Int AIDS Soc. 2013 Jun 10;16(1):18490. doi: 10.7448/IAS.16.1.18490.
INTRODUCTION
Retention in HIV care prior to ART initiation is generally felt to be suboptimal, but has not been well-characterized.
METHODS
We examined data on 37,352 adult pre-ART patients (ART ineligible or unknown eligibility) who enrolled in care during 2005-2008 with >1 clinical visit at 23 clinics in Mozambique. We defined loss to clinic (LTC) as >12 months since the last visit among those not known to have died/transferred. Cox proportional-hazards models were used to examine factors associated with LTC, accounting for clustering within sites.
RESULTS
Of 37,352 pre-ART patients, 61% had a CD4 count within three months of enrolment (median CD4: 452, IQR: 345-611). 17,598 (47.1%) were ART ineligible and 19,754 (52.9%) were of unknown eligibility status at enrolment because of missing information on CD4 count and/or WHO stage. Kaplan-Meier estimates for LTC at 12 months were 41% (95% CI: 40.2-41.8) and 48% (95% CI: 47.2-48.8), respectively. Factors associated with LTC among ART ineligible patients included male sex (AHR(men_vs_non-pregnant women): 1.5; 95% CI: 1.4-1.6) and being pregnant at enrolment (AHR(pregnant_vs_non-pregnant women): 1.3; 95% CI: 1.1-1.5). Older age, more education, higher weight and more advanced WHO stage at enrolment were independently associated with lower risks of LTC. Similar findings were observed among patients whose ART eligibility status was unknown at enrolment.
CONCLUSIONS
Substantial LTC occurred prior to ART initiation among patients not yet known to be eligible for ART, including nearly half of patients without documented ART eligibility assessment. Interventions are needed to target pre-ART patients who may be at higher risk for LTC, including pregnant women and patients with less advanced HIV disease.
简介
在开始接受抗逆转录病毒治疗(ART)之前,HIV 患者的保留率普遍较低,但尚未得到充分描述。
方法
我们检查了 2005 年至 2008 年间在莫桑比克 23 个诊所接受治疗的 37352 名成人 ART 前患者(ART 无资格或资格不明)的数据,这些患者在就诊时至少有一次就诊,且就诊时间超过 12 个月。我们将失去诊所(LTC)定义为在没有死亡/转移记录的患者中,自上次就诊以来的时间超过 12 个月。使用 Cox 比例风险模型来检查与 LTC 相关的因素,同时考虑到站点内的聚类。
结果
在 37352 名接受 ART 前的患者中,61%的患者在入组后三个月内有 CD4 计数(中位数 CD4:452,IQR:345-611)。17598 名(47.1%)患者无 ART 资格,19754 名(52.9%)患者在入组时因 CD4 计数和/或世卫组织分期信息缺失而无法确定资格,因此资格不明。12 个月时 LTC 的 Kaplan-Meier 估计值分别为 41%(95%CI:40.2-41.8)和 48%(95%CI:47.2-48.8)。在无 ART 资格的患者中,与 LTC 相关的因素包括男性(男性与非妊娠女性的 HR(men_vs_non-pregnant women):1.5;95%CI:1.4-1.6)和入组时怀孕(HR(pregnant_vs_non-pregnant women):1.3;95%CI:1.1-1.5)。年龄较大、受教育程度较高、体重较高和入组时世卫组织分期较高与 LTC 风险降低独立相关。在入组时 ART 资格不明的患者中也观察到类似的发现。
结论
在尚未确定有资格接受 ART 的患者中,在开始接受 ART 治疗之前,大量患者发生 LTC,包括近一半没有记录 ART 资格评估的患者。需要针对可能面临较高 LTC 风险的预 ART 患者,包括孕妇和 HIV 疾病程度较低的患者,采取干预措施。